More recently, AlShamaileh et al. reported showed that EpCAM-aptamer-guided surviving RNAi effectively downregulated survivin expression both in colorectal cancer cells in vitro and in a mouse xenograft model for colorectal cancer. This evidence concerns the gene EPCAM and colorectal cancer.